Literature DB >> 16885546

Measles in the United States, 2006.

E Kim Mulholland1.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16885546     DOI: 10.1056/NEJMp068149

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Evaluation of the Bio-Rad BioPlex Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG multiplex bead immunoassay.

Authors:  Matthew J Binnicker; Deborah J Jespersen; Leonard O Rollins
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

2.  Measles outbreaks affecting children in Jewish ultra-orthodox communities in Jerusalem.

Authors:  C Stein-Zamir; G Zentner; N Abramson; H Shoob; Y Aboudy; L Shulman; E Mendelson
Journal:  Epidemiol Infect       Date:  2007-04-16       Impact factor: 2.451

3.  STAT2 is a primary target for measles virus V protein-mediated alpha/beta interferon signaling inhibition.

Authors:  Aparna Ramachandran; Jean-Patrick Parisien; Curt M Horvath
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

4.  Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign.

Authors:  Heath A Kelly; Heather F Gidding; Theo Karapanagiotidis; Jennie A Leydon; Michaela A Riddell
Journal:  BMC Public Health       Date:  2007-06-08       Impact factor: 3.295

5.  Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial.

Authors:  Sanjay Lalwani; Sukanta Chatterjee; Sundaram Balasubramanian; Ashish Bavdekar; Shailesh Mehta; Sanjoy Datta; Michael Povey; Ouzama Henry
Journal:  BMJ Open       Date:  2015-09-11       Impact factor: 2.692

6.  [Travelling epidemics].

Authors:  M Rey
Journal:  Antibiotiques (Paris)       Date:  2008-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.